Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Assets Average (2016 - 2025)

Ocular Therapeutix (OCUL) has 12 years of Assets Average data on record, last reported at $609.5 million in Q4 2025.

  • For Q4 2025, Assets Average rose 28.54% year-over-year to $609.5 million; the TTM value through Dec 2025 reached $609.5 million, up 28.54%, while the annual FY2025 figure was $633.0 million, 78.31% up from the prior year.
  • Assets Average reached $609.5 million in Q4 2025 per OCUL's latest filing, up from $431.1 million in the prior quarter.
  • Across five years, Assets Average topped out at $609.5 million in Q4 2025 and bottomed at $125.6 million in Q2 2023.
  • Average Assets Average over 5 years is $301.9 million, with a median of $230.5 million recorded in 2021.
  • Peak YoY movement for Assets Average: crashed 30.38% in 2023, then surged 320.51% in 2024.
  • A 5-year view of Assets Average shows it stood at $211.3 million in 2021, then decreased by 27.15% to $153.9 million in 2022, then surged by 34.62% to $207.2 million in 2023, then surged by 128.81% to $474.2 million in 2024, then grew by 28.54% to $609.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Assets Average were $609.5 million in Q4 2025, $431.1 million in Q3 2025, and $428.6 million in Q2 2025.